Recurrent COVID-19 Diagnosis

Recurrent COVID-19 Diagnosis


The study duration: 24 Weeks.
Participants will attend 10 study site visits.
 
Compensation package includes:
$100 to patient for each site visit
All study medication, assessments and examinations are free to the participants.
 
Inclusion Questions:
Has the patient completion of a 5-day course of Paxlovid within the last 14 day?
Has the patient tested positive for COVID-19 in the last 24 hours? (YES/ NO)
Is the patient experiencing any symptoms of COVID-19?
 
Patient’s other medical conditions:
 
Inclusion Criteria
Participants are eligible to be included in the study only if all the following criteria apply:
  1. Participants aged 12 years or older
  2. Currently positive for COVID-19
  3. Participants must have written documentation showing completion of a 5-day course of Paxlovid (nirmatrelvir/ritonavir). 
  4. They must have symptom alleviation or resolution in COVID-19 signs/symptoms followed by a worsening (rebound) of signs/symptoms after completing an initial 5-day course of Paxlovid (nirmatrelvir/ritonavir).
  5. The onset of rebound in COVID-19 symptoms must occur within 2 weeks (14 days) after the completion of the initial 5-day course of nirmatrelvir/ritonavir.
 
You can have them call us at the number below and we will assess them for eligibility.

 

Sign Up For Clinical Trials Now, Cash Payments for Most Studies Up to $1500, Free Medical Care